Test Overview
Test Methodology
Next generation sequencing
Test Usage
Evaluation of hematologic neoplasms, specifically of myeloid origin (eg, acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, myelodysplastic/myeloproliferative neoplasm) at the time of diagnosis or possibly disease relapse, to help determine diagnostic classification and provide prognostic or therapeutic information for clinical management
Reference Range *
An interpretive report is provided
Test Details
Days Set Up
Monday, Wednesday, Friday
Analytic Time
15 - 22 days
Soft Order Code
NGSHM
Laboratory
Sendout
Reference Laboratory
Mayo NGSHM
Section
Special Testing
Specimen Requirements
Collection Instructions
Collect specimen in an EDTA or ACD tube and send to Specimen Processing at room temperature. (refrigerated acceptable)
Alternate Specimen
Heparin specimens are acceptable, but not preferred. Ambient is preferred, but refrigerated is acceptable.
Extracted DNA is acceptable (send frozen/refrig/ambient)
Extracted DNA is acceptable (send frozen/refrig/ambient)
Normal Volume
2 mL Whole blood, or bone marrow
Minimum Volume
1 mL Whole blood, or bone marrow
Billing
CPT Code
81450
NY State Approved
No